Irène Teyssandier
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Erythropoietin and Anemia Treatment 1
- Platelet Disorders and Treatments 1
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Immunology top 5%
- Rheumatology top 10%
- Eosinophilic Disorders and Syndromes 2
-
- Neutropenia and Cancer Infections 1
-
- Hematological disorders and diagnostics 1
- Co-authors
- Nicole CasadevallValérie UgoBruno VaretPatrick MayeuxJ NatafPatrick A. MichaudB VironP Martin-Dupont
- Cited by
- HematologyGeneticsImmunology
In The Last Decade
Irène Teyssandier
8 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Hematology 581
- Genetics 353
- Immunology 470
- Radiology, Nuclear Medicine and Imaging 235
- Rheumatology 131
Countries citing papers authored by Irène Teyssandier
This map shows the geographic impact of Irène Teyssandier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irène Teyssandier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irène Teyssandier more than expected).
Fields of papers citing papers by Irène Teyssandier
This network shows the impact of papers produced by Irène Teyssandier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irène Teyssandier. The network helps show where Irène Teyssandier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Irène Teyssandier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 4 | |
| 2 | 2009 | 43 | |
| 3 | 2007 | 143 | |
| 4 | 2006 | 18 | |
| 5 | 2004 | 127 | |
| 6 | Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietinbreakdown → | 2002 | 843 |
| 7 | Prognostic and diagnostic value of endogenous erythroid colony formation in essential thrombocythemia. | 1998 | 8 |
| 8 | [Expansion of erythropoiesis and granulopoiesis after bone marrow grafts]. | 1986 | 1 |
About Irène Teyssandier
Irène Teyssandier is a scholar working on Hematology, Genetics and Rheumatology, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Erythropoietin and Anemia Treatment (1 paper), Neutropenia and Cancer Infections (1 paper), Platelet Disorders and Treatments (1 paper) and Hematological disorders and diagnostics (1 paper). The work is most often cited by research in Hematology (581 citations), Genetics (353 citations) and Immunology (470 citations). Irène Teyssandier has collaborated with scholars based in France and Belize. Frequent co-authors include Nicole Casadevall, Valérie Ugo, Bruno Varet, Patrick Mayeux, J Nataf, Patrick A. Michaud, B Viron, P Martin-Dupont, Jean‐Jacques Kiladjian and T. Papo. Their work appears in journals such as Blood, Clinical Cancer Research, Transplantation, Experimental Hematology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.